Post-approval studies (Phase 4)Study completedNCT00231894
What this trial is testing
Pioglitazone as a Treatment for Lipid and Glucose Abnormalities In Patients With Schizophrenia
Who this might be right for
DiabetesSchizophreniaInsulin Resistance+1 more
Nathan Kline Institute for Psychiatric Research 56